Editors-in-Chief and 3 Editorial Board Members Recognized in the World's Top 2% Scientists 2026

We are proud to announce that Professor Giuseppe Lanza, Editors-in-Chief of  of Advances in Clinical and Translational Medicine (ACTM), together with 3 distinguished Editorial Board members, have been named on the World's Top 2% Scientists 2026 list. This prestigious accolade acknowledges their outstanding research contributions and far-reaching global impact across clinical medicine, translational research, and related biomedical domains.

This remarkable milestone attests to the exceptional academic caliber of the ACTM editorial team and underscores the journal’s commitment to advancing high-quality, impact-driven research. Under the stewardship of our Editor-in-Chief, ACTM serves as an international platform for pioneering investigations, scholarly exchange, and innovation within clinical and translational medicine.

We offer our sincere congratulations to Professor Giuseppe Lanza and all distinguished Editorial Board members.

Editorial Board Members Recognized in the World's Top 2% Scientists 2026

Muhammad Kashif      Ibadat International University Islamabad, Pakistan

Hamid Tebyaniyan      Department of Science and Research, Islamic Azad University, Tehran, Iran

Ambika Binesh            Tamil Nadu Dr J Jayalalithaa Fisheries University, India